ACADIA Pharmaceuticals Inc. (ACAD) Financial Statements (2026 and earlier)

Company Profile

Business Address 12830 EL CAMINO REAL
SAN DIEGO, CA 92130
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments755,993438,865416,823520,706631,958697,429
Cash and cash equivalent319,589188,657114,846147,435326,028189,680
Short-term investments436,404250,208301,977373,271305,930507,749
Receivables104,695102,35063,08065,34450,28237,874
Inventory, net of allowances, customer advances and progress billings91,69040,44711,56014,0989,6826,341
Inventory91,69040,44711,56014,0989,6826,341
Prepaid expense55,68139,09121,39823,89225,69418,606
Other undisclosed current assets(69,741)(4,628)(4,924)(6,217)  
Total current assets:938,318616,125507,937617,823717,616760,250
Noncurrent Assets
Operating lease, right-of-use asset46,57151,85555,57358,26847,2839,524
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization4,2154,6126,0218,0479,1613,180
Intangible asset, including goodwill, after accumulated amortization119,78265,490  1,1082,585
Intangible asset, excluding goodwill, after accumulated amortization119,78265,490  1,1082,585
Restricted cash and investments8,7705,7705,7705,7705,7704,787
Deferred income tax assets      
Other noncurrent assets3594767,5873,9971,6782,857
Other undisclosed noncurrent assets69,7414,6284,9246,217  
Total noncurrent assets:249,438132,83179,87582,29965,00022,933
TOTAL ASSETS:1,187,756748,956587,812700,122782,616783,183
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities394,870254,254125,63096,068105,96774,826
Accounts payable16,19217,54312,7466,8768,4937,222
Accrued liabilities378,678236,711112,88489,19297,47467,604
Total current liabilities:394,870254,254125,63096,068105,96774,826
Noncurrent Liabilities
Long-term debt and lease obligation:    56,12644,4606,361
Liabilities, other than long-term debt60,09362,94761,7697,0345,1802,861
Other liabilities18,05615,1479,0747,0345,1802,861
Operating lease, liability42,03747,80052,69556,12644,4606,361
Total noncurrent liabilities:60,09362,94761,76963,16049,6409,222
Total liabilities:454,963317,201187,399159,228155,60784,048
Equity
Equity, attributable to parent732,793431,755400,413540,894627,009699,135
Common stock161616161615
Additional paid in capital2,936,8712,862,5522,770,9232,694,6462,612,6632,402,945
Accumulated other comprehensive income (loss)29224(975)(192)36297
Accumulated deficit(2,204,386)(2,430,837)(2,369,551)(2,153,576)(1,985,706)(1,704,122)
Total equity:732,793431,755400,413540,894627,009699,135
TOTAL LIABILITIES AND EQUITY:1,187,756748,956587,812700,122782,616783,183

Income Statement (P&L) ($ in thousands)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues957,797726,437517,235484,145441,755339,076
Cost of revenue(213,393)(41,638)(10,166)(19,141)(20,550)(19,598)
Cost of product and service sold(81,841)(41,638)(10,166)(10,843)(10,211)(11,344)
Other undisclosed gross profit   (1)8,29810,3398,254
Gross profit:744,404684,799507,068473,302431,544327,732
Operating expenses(513,610)(758,178)(730,665)(635,443)(707,791)(566,023)
Other undisclosed operating income (loss)   1(8,298)(10,339)(8,254)
Operating income (loss):230,794(73,379)(223,596)(170,439)(286,586)(246,545)
Nonoperating income (expense)1,8235,1093,542(2,329)(1,994)1,994
Investment income, nonoperating     (997)997
Other nonoperating income (expense)1,8235,1093,542(2,329)(997)997
Other undisclosed income from continuing operations before equity method investments, income taxes     7,60710,168
Income (loss) from continuing operations before equity method investments, income taxes:232,617(68,270)(220,054)(172,768)(280,973)(234,383)
Other undisclosed income from continuing operations before income taxes25,45817,2346,6105,249  
Income (loss) from continuing operations before income taxes:258,075(51,036)(213,444)(167,519)(280,973)(234,383)
Income tax expense (benefit)(31,624)(10,250)(2,531)(351)(611)(876)
Income (loss) from continuing operations:226,451(61,286)(215,975)(167,870)(281,584)(235,259)
Loss before gain (loss) on sale of properties:(167,870)(281,584)(235,259)
Net income (loss) available to common stockholders, diluted:226,451(61,286)(215,975)(167,870)(281,584)(235,259)

Comprehensive Income ($ in thousands)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net income (loss):226,451(61,286)(215,975)(167,870)(281,584)(235,259)
Other comprehensive income (loss)268999(783)(228)(261)669
Comprehensive income (loss), net of tax, attributable to parent:226,719(60,287)(216,758)(168,098)(281,845)(234,590)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: